Morning Overview on MSN
The FDA approved an updated LP.8.1 COVID vaccine for adults 65 and older and high-risk people ages 5 through 64
Adults 65 and older, along with people ages 5 through 64 who face elevated risk from COVID-19, now have access to an updated vaccine matched to a strain that has been circulating widely. The FDA ...
Morning Overview on MSN
A new antiviral pill won approval to help prevent COVID-19 after a known exposure
Households exposed to COVID-19 now have an oral drug specifically cleared to prevent infection after contact with a sick ...
UK experts say protection against hospitalisation still 90% three months after booster; Germany also cuts isolation for boosted people after a Covid contact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results